Successful Treatment with Upadacitinib of Patient with Persistent Head and Neck Atopic Dermatitis Refractory to Dupilumab: A Case Report.

The article presents a case study of a 37-year-old woman with persistent head and neck atopic dermatitis (AD) unresponsive to dupilumab, who showed significant improvement after switching to upadacitinib. It highlights the challenges and potential adverse effects associated with dupilumab, such as conjunctivitis and erythema, and demonstrates upadacitinib's efficacy as an alternative treatment.